| GA20290-1g |
|
90742-94-2 |
(S)-3-Isopropylamino-1,2-propanediol
|
0 |
C6H15NO2 |
|
|
|
| GA20289-25g |
|
62247-21-6 |
(RS)-3-Amino-3-(3-pyridyl)-propionic acid
|
0 |
C8H10N2O2 |
|
|
|
| GA20289-5g |
|
62247-21-6 |
(RS)-3-Amino-3-(3-pyridyl)-propionic acid
|
0 |
C8H10N2O2 |
|
|
|
| GA20289-1g |
|
62247-21-6 |
(RS)-3-Amino-3-(3-pyridyl)-propionic acid
|
0 |
C8H10N2O2 |
|
|
|
| GA20288-25g |
|
97988-45-9 |
(R)-3-Isopropylamino-1,2-propanediol
|
0 |
C6H15NO2 |
|
|
|
| GA20288-5g |
|
97988-45-9 |
(R)-3-Isopropylamino-1,2-propanediol
|
0 |
C6H15NO2 |
|
|
|
| GA20288-1g |
|
97988-45-9 |
(R)-3-Isopropylamino-1,2-propanediol
|
0 |
C6H15NO2 |
|
|
|
| GA20287-5mg |
|
79775-19-2 |
(Pyr⁶,Pro⁹)-Substance P (6-11)
|
0 |
C39H53N7O7S |
|
|
|
| GA20287-1mg |
|
79775-19-2 |
(Pyr⁶,Pro⁹)-Substance P (6-11)
|
0 |
C39H53N7O7S |
|
|
|
| GA20286-25mg |
|
77128-69-9 |
(Pyr⁵,N-Me-Phe⁸,Sar⁹)-Substance P (5-11)
|
0 |
C43H61N9O9S |
|
|
|
| GA20286-5mg |
|
77128-69-9 |
(Pyr⁵,N-Me-Phe⁸,Sar⁹)-Substance P (5-11)
|
0 |
C43H61N9O9S |
|
|
|
| GA20285-1mg |
|
183449-57-2 |
(Pyr³)-Amyloid β-Protein (3-42)
|
0 |
C196H299N53O55S |
|
|
|
| GA20285-005mg |
|
183449-57-2 |
(Pyr³)-Amyloid β-Protein (3-42)
|
0 |
C196H299N53O55S |
|
|
|
| GA20284-1mg |
|
183449-57-2 |
(Pyr³)-Amyloid β-Protein (3-42)
|
0 |
C196H299N53O55S |
|
|
|
| GA20284-005mg |
|
183449-57-2 |
(Pyr³)-Amyloid β-Protein (3-42)
|
0 |
C196H299N53O55S |
|
|
|
| GA20283-1mg |
|
161818-04-8 |
(Pyr³)-Amyloid β-Protein (3-40)
|
0 |
C187H283N51O53S |
|
|
|
| GA20283-005mg |
|
161818-04-8 |
(Pyr³)-Amyloid β-Protein (3-40)
|
0 |
C187H283N51O53S |
|
|
|
| GA20282-1mg |
|
192377-94-9 |
(Pyr¹¹)-Amyloid β-Protein (11-40)
|
0 |
C143H226N38O39S |
|
|
|
| GA20282-005mg |
|
192377-94-9 |
(Pyr¹¹)-Amyloid β-Protein (11-40)
|
0 |
C143H226N38O39S |
|
|
|
| GA20281-5mg |
|
121250-95-1 |
(Propionyl¹,D-Tyr(Et)²,Val⁴,Abu⁶,Arg⁸·⁹)-Vasopressin
|
0 |
C53H82N16O11 |
|
|
|
